Praxis Precision Medicines, Inc.
ION CHANNEL MODULATORS

Last updated:

Abstract:

Provided, in part, are compounds of Formula I: ##STR00001## pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of conditions associated with the activity of sodium channels. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including neurological disorders (e.g., Dravet syndrome, epilepsy), pain, and neuromuscular disorders are also provided herein.

Status:
Application
Type:

Utility

Filling date:

4 Mar 2022

Issue date:

30 Jun 2022